Intrapace

About:

Intrapace develops a novel implantable system to treat obesity.

Website: http://intrapace.com

Top Investors: Oxford Bioscience Partners, Excel Venture Management, Johnson & Johnson Development Corporation, The Halo Fund, Toucan Capital

Description:

IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.